(KRRO) Investment Analysis - news.stocktradersdaily.com
Yesterday • Google News
Frequency Therapeutics Inc (KRRO)
US$ 37.3-1.74%
Price Chart
Key Statistics
Market Cap
$ 139.45M
P/E Ratio
0.00
Revenue (TTM)
$ 4.82M
Volume
53.9K
52W High
$ 98.00
52W Low
$ 10.29
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
14.9084
200-Day MA
34.6379
52 Week High
98
52 Week Low
10.29
About KRRO
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent disea.
Employees
112
Headquarters
Cambridge, MA
CEO
Dr. Ram Aiyar MBA, Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg